Literature DB >> 9584269

Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency).

R Barone1, H Carchon, E Jansen, L Pavone, A Fiumara, N U Bosshard, R Gitzelmann, J Jaeken.   

Abstract

From 10 patients with carbohydrate-deficient glycoprotein (CDG) syndrome due to phosphomannomutase (PMM) deficiency, out of 10 lysosomal enzymes, 7 enzyme activities were measured in serum and 9 in leukocytes. In serum there was a 2-fold to 4-fold increase in activity of beta-glucuronidase, beta-hexosaminidase, beta-galactosidase, and arylsulphatase A. In leukocytes, however, several enzymes had reduced activity, particularly alpha-fucosidase, beta-glucuronidase and alpha-mannosidase. These abnormalities could result from missorting, defective reuptake and/or reduced stability of the enzymes due to the defective glycosylation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9584269     DOI: 10.1023/a:1005351927573

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

1.  The assay of arylsulphatases A and B in human urine.

Authors:  H BAUM; K S DODGSON; B SPENCER
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

Review 2.  The carbohydrate-deficient glycoprotein syndrome. A new inherited multisystemic disease with severe nervous system involvement.

Authors:  J Jaeken; H Stibler; B Hagberg
Journal:  Acta Paediatr Scand Suppl       Date:  1991

3.  Disialotransferrin developmental deficiency syndrome.

Authors:  B Kristiansson; M Andersson; B Tonnby; B Hagberg
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

4.  Olivopontocerebellar atrophy leading to recognition of carbohydrate-deficient glycoprotein syndrome type I.

Authors:  L Pavone; A Fiumara; R Barone; R Rizzo; P Buttitta; W B Dobyns; J Jaeken
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

5.  Human leukocyte acid hydrolases: characterization of eleven lysosomal enzymes and study of reaction conditions for their automated analysis.

Authors:  E H Kolodny; R A Mumford
Journal:  Clin Chim Acta       Date:  1976-07-15       Impact factor: 3.786

Review 6.  The carbohydrate-deficient glycoprotein syndrome: an experiment of nature in glycosylation.

Authors:  B Winchester; P Clayton; N Mian; E di-Tomaso; A Dell; A Reason; G Keir
Journal:  Biochem Soc Trans       Date:  1995-02       Impact factor: 5.407

Review 7.  The carbohydrate-deficient glycoprotein syndromes: pre-Golgi and Golgi disorders?

Authors:  J Jaeken; H Carchon; H Stibler
Journal:  Glycobiology       Date:  1993-10       Impact factor: 4.313

8.  Carbohydrate-deficient glycoprotein syndrome with previously unreported features.

Authors:  F Eyskens; C Ceuterick; J J Martin; G Janssens; J Jaeken
Journal:  Acta Paediatr       Date:  1994-08       Impact factor: 2.299

9.  Carbohydrate-deficient glycoprotein syndrome: clinical expression in adults with a new metabolic disease.

Authors:  H Stibler; G Blennow; B Kristiansson; H Lindehammer; B Hagberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

10.  Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I.

Authors:  E Van Schaftingen; J Jaeken
Journal:  FEBS Lett       Date:  1995-12-27       Impact factor: 4.124

View more
  5 in total

1.  Abnormal lysosomal inclusions in liver hepatocytes but not in fibroblasts in congenital disorders of glycosylation (CDG).

Authors:  S Grünewald; R De Vos; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

2.  Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and N-glycosylation disorder.

Authors:  L J M Spaapen; J A Bakker; S B van der Meer; H J Sijstermans; R A Steet; R A Wevers; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 3.  Carbohydrate-deficient glycoprotein syndromes.

Authors:  N Gordon
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

4.  Serum N-acetyl-beta-D-glucosaminidase profiles in type 1 diabetes secondary complications: causes of changes and significance of determination.

Authors:  V B Jovanović; V S Dimitrijević-Srecković; Ljuba M Mandić
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

5.  Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation.

Authors:  Christina Lam; Carlos Ferreira; Donna Krasnewich; Camilo Toro; Lea Latham; Wadih M Zein; Tanya Lehky; Carmen Brewer; Eva H Baker; Audrey Thurm; Cristan A Farmer; Sergio D Rosenzweig; Jonathan J Lyons; John M Schreiber; Andrea Gropman; Shilpa Lingala; Marc G Ghany; Beth Solomon; Ellen Macnamara; Mariska Davids; Constantine A Stratakis; Virginia Kimonis; William A Gahl; Lynne Wolfe
Journal:  Genet Med       Date:  2016-07-07       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.